 |
||
|
||
<< back to Dr. Gualtieri's medical background
Articles:
Mulvey RS, Gualtieri RJ, and Beychok S: Spectral properties of human lysozyme and its inhibitor complexes. Fluorescence and difference spectra. Biochemistry 12:2683-2690, 1973.
Mulvey RS, Gualtieri RJ, and Beychok S: Composition, fluorescence and circular dichroism of rat lysozyme. Biochemistry 13:782-787, 1974.
Mulvey RS, Gualtieri RJ, and Beychok S: Comparative studies of the solution behavior of hen egg white and human lysozyme. In: Lysozyme Osserman EF, Canfield RE, and Beychok S (eds), Academic Press, New York, New York, pp. 281 – 300, 1974.
Bertram J, Gualtieri RJ, and Osserman EF: Amyloid-related Bence-Jones proteins bind dinitrophenyl L-lysine (DNP). In: Amloid and Amyloidosis Glenner GG, Costa PP, and Freitas F (eds), Amsterdam: Excerpta Medica, pp. 351 – 360, 1980.
Freidman CJ, Gualtieri RJ, Finney MD, and Hodge RH: Clinocopathologic conference: Massive hematemesis. Virginia Medical 109:459-467, 1982.
Scheld WM, Gualtieri RJ, and Finney MD: Grand Rounds: North American blastomycoses. Virginia Medical 110:240-248, 1983.
Gualtieri RJ, Donowitz GR, Kaiser DL, Hess CE, and Sande MA: Double blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. American Journal of Medicine 74-934-940, 1983.
Quesenberry PJ, Coppola MA, Gualtieri RJ, Wade PM, Song Z, Doukas MA, Shedeler CE, Baker DG, and McGrath EH: Lithium stimulation of murine hematopoiesis in a liquid culture system: An effect mediated by radioresistant stromal cells. Blood 63:121 – 127, 1984.
Gualtieri RJ, Shadduck RK, Baker DG, and Quesenberry PJ: Hematopoietic regulatory factors produced in long term murine bone marrow cultures and the effect of in vitro irradiation. Blood 64516 – 525, 1984.
Gualtieri RJ, and Wheby MS: Hairy cell leukemia: A case of cryptococcosis presenting as hairy cell meningitis. Southern Medical Journal 77:1341 – 1342, 1984.
Quesenberry PJ, Song ZX, Gualtieri RJ, Wade PM, Jr., Alberico TA, Stewart FM, Doukas MA, Levitate L, McGrath HE, Rebreed LA, and Nines DJ: Studies of the control of hemopoiesis in Dexter culture. In: Long Term Bone Marrow Culture Wright DG and Greenberger JS (eds), A.R. Liss Inc., New York, New York, pp 171– 193, 1984.
Quesenberry P. Alberico T, Song Z, Donowitz G, Stewart M, Gualtieri RJ, Boswell S, McGrath E, Kleeman E, Barber G, and Craston S: Studies on the regulation of hemopoiesis in Dexter culture. Experimental Hematology (Suppl. 16) 13:43 – 48, 1985.
Johnson P, Gualtieri RJ, Mohler DN, and Carpenter JT: Autoimmune hemolytic anemia associated with a hypernephroma. Southern Medical Journal 78:1129 – 1131, 1985.
Quesenberry P, Song Z, Alberico T, Gualtieri RJ, Stewart M, Innes D, McGrath E, Cranston S, and Kleeman E: Bone marrow adherent cell hemopoietic growth factor production. In: Hematopoietic Stem Cell Physiology; Cronkite EP, Daniak N, McCaffrey RP, Palk J and Quesenberry PJ (eds). Alan R. Liss, Inc., New York, NY, pp 247 – 256, 1985.
Gualtieri RJ, Berne RM, McGrath B, Huster WJ and Quesenberry PJ: Effect of adenine nucleotides on granulopoiesis and lithium induced granulocytosis in long term bone marrow cultures. Experimental Hematology 14:689, 1986.
Gualtieri RJ, Liang C-M, Shadduck RK, Waheed A, and Banks J: Identification of the hematopoietic growth factors elaborated by bone marrow stromal cells by antibody neutralization analysis. Experimental Hematology 15:883 – 889, 1987.
Gualtieri RJ: Consequences of extremely high doses of irradiation on bone marrow stromal cells and the release of hematopoietic growth factors. Experimental Hematology 15:952 – 957, 1987.
Coetzer TL, Lawler J, Liu SC, Prchal JT, Gualtieri RJ, Brain MC, Dacie J, Palek J: Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis. New England Journal of Medicine 318:230 – 234, 1988.
Barton JC, Parmley RT, Butler TW, Williamson S, Lilly MD, Gualtieri RJ and Heck LW: Differential staining of neutrophils and monocytes: Surface and cytoplasmic iron-binding proteins. Histochemical Journal 20:147 – 155, 1988.
Gualtieri RJ, Castleberry RP, Gibbons J, Miller DM, Parmley RT, Berkow RL, and Banks J: Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia. Experimental Hematology 16:613 – 619, 1988.
Quesenberry PJ, Thomas C, Alberico TA, Landreth K, Witte P, He Y, Song Z, Gualtieri RJ, McGrath HE, Kleeman E, Baber G, and Innes D: Hematopoietic growth factor production by marrow stromal cells. In: Proceedings of the symposium on humoral and cellular regulation of erythropoiesis, Alan R. Liss, Inc., New York, NY, 1988.
Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shaw RK, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML, Dickerson JD, Hahami N, and Castleberry RP: Granulocyte-macrophage colony stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 47:2360 – 2364, 1989.
Emanuel PD, Barton JC, Gualtieri RJ, and Sams WM: Urticaria pigmentosa and preleukemia: Evidence for reactive mast cell proliferation. American Journal of Dermatology, 24:893 – 897, 1991.
Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Hypersensitivity to GM-CSF by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925 – 929, 1991.
Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. The role of monocyte-derived hemopoietic growth factors in the regulation of the myeloproliferation in juvenile chronic myelogenous leukemia. Experimental Hematology 19:1017 – 1024, 1991.
Cramer RC, Aboko-Cole V, Gualtieri RJ. Agranulocytosis associated with Etodoloc. Annals Phar., 28:458 – 460, 1994.
Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd RL, Homans A, Chaffee S, Nitschke R, Gualtieri RJ. A Pilot study of 13-Cis retinoic acid in the treatment of juvenile chronic myelogenous leukemia. New England Journal of Medicine, 331:1680 – 1684, 1994.
McClendon RE, Bentley RC, Parisi JE, Feisberg GJ, Tien RD, Harrison JC, Tarbell N, Billitt AL, Gualtieri RJ, Friedman HS. Malignant supratentorial glial-neuronal neoplasms. Report of two cases and review of the literature. Arch Pathol Lab Med, 121:485 – 492, 1997.
Abstracts:
A1. Gualtieri RJ, Donowitz G, Hess CE, and Sande MA: Double blind randomized study of prophylactic trimethoprim/sulfamethoxazole in
granulocytopenic patients with hematologic malignancies. Abstracts of the 12th International Congress of Chemotherapy, Florence, Italy, p. 118,
1981.
A2. Gualtieri RJ and Quesenberry PJ: Production of colony stimulating activity by murine bone marrow stroma following in vitro irradiation. Journal of
Cellular Biochemistry (Suppl. 6): 227, 1982.
A3. Gualtieri RJ and Quesenberry PJ: Effect of raiation on the production of colony stimulating activity by murine bone marrow. Clinical Research 20
(2): 418A, 1982.
A4. Gualtieri RJ and Quesenberry PJ: Lithium stimulated hemopoiesis and the effect of adenine nucleotides in long term murine bone marrow cultures.
Experimental Hematology 10 (Suppl. 11): 98, 1982.
A5. Gualtieri RJ, Shadduck RK, and Quesenberry PJ: Characteristics of hematopoietic regulatory factors produced by long term murine marrow
cultures. Blood 60 (Suppl. 1): 98a, 1982.
A6. Gualtieri RJ, Shadduck RK, and Quesenberry PJ: Hematopoietic stem cell regulators in long term bone marrow cultures. Clinical Research 30
(5): 872A, 1982.
A7. Alberico TA, Ihle JN, McGrath HE, Gualtieri RJ, Rexrode LA, and Quesenberry PJ: Characteristics of colony-forming cells maintained in Dexter
culture and possible regulators involved in their maintenance. Blood 62 (Suppl. 1): 129A, 1983.
A8. Gualtieri RJ, Shadduck RK, and McGraw J: Measurement of hematopoietic growth factor (CSF1) secretion by individual cells. Blood 66 (Suppl.
1): 152a, 1985.
A9. Gualtieri RJ and McGraw J: Bone marrow stromal cells survive megadose irradiation and continue to produce hematopoietic growth factor(s).
Blood 66 (Suppl. 1): 152a, 1985.
A10. Simpson JA, Zuckerman KS, Gualtieri RJ, and Kubagawa H: Separation of erythroid and granulocytic precursors based upon expression of FC6
antigen. Federation Proceedings 45:720, 1986.
A11. Gualtieri RJ, Castleberry RP, Gibbons J, Miller DM, Berkow RL and Banks J: Unique in vitro culture characteristics in juvenile type chronic
myelogenous leukemia. Clinical Research 34:459a, 1986.
A12. Coetzer TL, Lawler J, Prchal JT, Gualtieri RJ, and Palek J: Partial ankyrin deficiency and spectrin deficiency in severe hereditary spherocytosis.
Blood 68:54a, 1986.
A13. Gualtieri RJ, Liang C-M, and Shadduck RK: Bone marrow stromal cells from long term marrow cultures elaborate CSF-1 and GM-CSF. Blood 68:
165a, 1986.
A14. Gualtieri RJ, Martin G, Shadduck RK, Liang CM, and Waheed A. Stromal cell dependent, stem-cell proliferation and the role of hematopoietic
stimulatory factors. Blood 70 (Suppl. 1): 172a, 1987.
A15. Barton JC, Sanchez JD, Parmely RT, Gualtieri RJ, Berkow RL, Lilly MB, Butler TW, Zuckerman KS and Carroll AJ. Chronic neutrophilic leukemia
(CNL): A distinctive myeloproliferative syndrome. Blood 70 (Suppl. 1): 197a, 1987.
A16. Gualtieri RJ, Castleberry RP, Martin G, Clark SC, Emanuel PD, Shaw AR, Shadduck RK, Dracker RA, Akabutu, Nitschke R. Granulocyte-
macrophage colony stimulating factor (GM-CSF) is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia (JCML).
Clinical Research, 36: 24a, 1988.
A17. Emanuel PD, Castleberry RP, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu JJ, Nitschke R, Hefferington ML, Hakami
N, Gualtieri RJ. Cell proliferation in juvenile chronic myrlogenous leukemia (JCML) as regulated by endogenously produced granulocyte-
macrophage colony stimulating factor (GM-CSF). Blood, 1988. Vol. 72 (Suppl. 1): 196a.
A18. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, and Zuckerman KS. Selective hypersensitivity to GM-CSF by hemopoietic progenitor cells
in juvenile chronic myelogenous leukemia. Blood, 1990. Vol. 76 (Suppl. 1) 142a.
A19. Emanuel PD, Bates LJ, Zhu S-W, Castleberry RP, Gualtieri RJ, and Zuckerman KS. GM-CSF dysregulation in juvenile chronic myelogenous
leukemia. Blood, 1990. Vol. 76 (Suppl.1): 1058a.
A20. Emanuel PD, Castleberry RP, Gualtieri RJ, Bates LJ, and Zuckerman KS. Hematopoietic growth factor and cytokine production by monocytes
isolated from patients with juvenile chronic myelogenous leukemia. Experimental Hematology, 1990. Vol. 19 (Suppl.1): 1017 – 1024.
A21. Castleberry RP, Emanuel PD, Gualtieri RJ, Zuckerman K, Cohn S, Strauss L, Byrd R, Homans A, Chaffee S, Nitschke R. Preliminary
experience with 13-CIS retinoic acid (CRA) in the treatment of juvenile chronic myelogenous leukemia (JCML). Blood, 1991. Vol. 78 (Suppl.1):
170a.
A22. Waples JM, Gualtieri RJ, Hon JK, Schreeder MT, Prasthofer EF, Heffelfinger R. High dose chemotherapy and stem cell transplantation in patients
with multiple myeloma treated with a monoclonal antibody against CD20 prior to stem cell collection. Blood, 2000. Vol. 96(11): 326b.
A23. Gray JR, Hainsworth JD, Burris HA, Morrissey LH, Gualtieri RJ, Joseph G, Steis R, Greco FA. Paclitaxel, carboplatin, and topotecan in the
treatment of small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network, Proc Am Soc Clin Oncol 2000: (Abstract
1931).
A24. Ross DT, Ring, RS, Seitz, WJ, Shasteen, R, Beck S, Chang Y, Wang CM, Perou RJ, Gualtieri RJ, Estopinal NC. Novel IHC reagents targeted by
gene expression data dentify poor prognosis breast cancer patients in a retrospective cohort at the Comprehensive Cancer Institute of Huntsville
(CCIH). Proc Am Soc Clin Oncol 2004: (Abstract 9612).
Letters:
L1. Gualtieri RJ, Walton G. Adult Respiratory Distress Syndrome induced by Antithymocyte Globulin. Archives of Internal Medicine, 1998. Vol.
158:1380.
L2. Gualtieri RJ, Walton G. Activated Protein C Resistance and Sneddon’s Syndrome. American Journal of Medicine, 1999. Vol. 107:293.